NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Of the four strategies being pursued by the National Cancer Institute (NCI) to advance their goal of cancer eradication, the effort to create large pools of readily shared data appears to be the one dearest to the heart of NCI director Norman E. Sharpless, MD.

https://www.medscape.com/viewarticle/907181

The article details his passion for molecular markers to improve treatment responses. An earlier article I read talked about his push to obtain data from the FDA from cancer trials.

This is promising:

To accept his post as NCI director, Dr Sharpless agreed to divest from investment interests, withdraw from industry advisory relationships, and relinquish titles to patents.